Buy the GCP R3 course & get a FREE eBook— your complete ICH-GCP R3 reference guide. Book Now →

  • Preclinical & Laboratory Foundations Learning Path
  • Phase I – First-in-Human Trials Learning Path
  • Phase II & III – Efficacy & Pivotal Trials Learning Path
  • Clinical Trials Foundation PathNew
  • Regulatory Submission & Approval

About

Oracle Empirica Signal: Practical Signal Detection & Management training provides the knowledge and practical skills required to understand, perform, and manage pharmacovigilance signal detection activities using Oracle Empirica Signal while applying global regulatory expectations for signal management. It equips learners with a strong foundation in safety signal concepts, disproportionality analysis, data mining methods, signal detection workflows, alert triage, signal validation, prioritisation, assessment, documentation, governance, and benefit-risk evaluation used within pharmaceutical, biotechnology, and drug safety environments.
This Oracle Empirica Signal: Practical Signal Detection & Management Course & Certification covers principles of signal detection and signal management, EudraVigilance and spontaneous reporting data concepts, drug-event combinations (DECs), MedDRA coding and Standardised MedDRA Queries (SMQs), disproportionality metrics including PRR, ROR, MGPS, and Information Component (IC), alert generation and triage, signal validation, prioritisation and assessment, clinical review of case series, confounding and bias considerations, signal tracking systems, ALCOA+ documentation principles, regulatory expectations under GVP Module IX, signal communication, risk minimisation actions, benefit-risk evaluation, and practical application of Oracle Empirica Signal workflows within regulatory-compliant pharmacovigilance systems. Upon successful completion, learners receive a certification demonstrating their understanding of practical signal detection methodologies, Oracle Empirica Signal workflows, pharmacovigilance signal management processes, and their application in pharmaceutical safety surveillance, regulatory compliance, and patient risk management.

Who Should Enrol?

  • Drug Safety and Pharmacovigilance Professionals
  • Pharmacovigilance Scientists and Signal Detection Specialists
  • Safety Physicians and Medical Reviewers
  • Risk Management and Benefit-Risk Assessment Professionals
  • Pharmacovigilance Case Processing and Aggregate Reporting Personnel
  • Clinical Safety and Patient Safety Professionals
  • Regulatory Affairs and Quality Assurance Professionals involved in pharmacovigilance
  • Pharmaceutical, Biotechnology, Vaccine, and CRO Personnel
  • Clinical Research Professionals seeking to expand into Drug Safety and Signal Management
  • Students, Graduates, and Professionals seeking a career in Pharmacovigilance, Drug Safety, and Regulatory Compliance
📢 Every purchase also includes our FREE companion Oracle Empirica Signal: Practical Signal Detection & Management eBook, designed to help you apply principles in real-world pharmaceutical medicine settings.

What you will learn

Understand the principles of pharmacovigilance signal detection, signal validation, signal prioritisation, and risk evaluation using Oracle Empirica Signal in pharmaceutical safety surveillance.

Learn how to identify, assess, and manage potential safety signals from spontaneous reporting databases while balancing statistical evidence, clinical judgement, data quality, regulatory expectations, and patient safety considerations.

Develop knowledge of disproportionality analysis, data mining techniques, PRR, ROR, EBGM, signal review workflows, case-series assessment, signal tracking, workflow management, and documentation within Oracle Empirica Signal.

Gain understanding of how signal detection outputs are interpreted, validated, escalated, and communicated, and apply best practices for efficient, compliant, and evidence-based signal management in accordance with GVP, FDA, and international pharmacovigilance requirements.

Course Syllabus

  1. How the course works and who it is for
  2. Positioning: regulatory requirement vs good practice vs Empirica workflow
  3. The Meridian Pharma fictional world
  4. Disproportionality is not causation; no signal is not no risk

  1. What a safety signal is (and is not)
  2. The signal-management lifecycle
  3. Quantitative and clinical methods together
  4. GVP IX and CIOMS VIII framework

  1. What Empirica Signal is for
  2. How safety data flows in
  3. Alerts, topics and workflow states
  4. Tool versus human; version-dependent terminology

  1. Sources of safety data
  2. Under-reporting and the missing denominator
  3. Reporting bias, stimulated reporting and the Weber effect
  4. Duplicates and data quality

  1. The drug-event combination
  2. MedDRA hierarchy, level choice and SMQs
  3. Building a case series
  4. Query design choices and reproducibility

  1. Observed versus expected reporting
  2. The 2x2 contingency table
  3. A worked 2x2 on fictional data
  4. Relative reporting, not causation

  1. Worked PRR and ROR on the same table
  2. Why PRR and ROR agree for rare events
  3. Confidence intervals and precision
  4. Alert thresholds and small-number instability

  1. Why Bayesian methods exist; shrinkage
  2. EBGM, EB05 and EB95
  3. The Information Component and IC025
  4. Comparing Bayesian scores with PRR/ROR

  1. Triaging a list of alerts
  2. Drilling from score to cases
  3. Labelled events and apparent increases
  4. Confounding and masking in review

  1. What validation is; the validation checklist
  2. Validated, not validated or watch
  3. What prioritisation is
  4. Prioritisation factors

  1. What assessment adds
  2. Integrating spontaneous, literature, trial and epidemiological evidence
  3. Causal viewpoints (Bradford Hill)
  4. Benefit-risk context, conclusion and recommendation

  1. Why tracking exists; the tracking system
  2. Governance and roles (SMT, QPPV)
  3. Documentation and ALCOA+
  4. Disciplined, defensible decision-making

  1. Graded regulatory and risk-minimisation actions
  2. Communication of new risks
  3. Continued monitoring and signal closure
  4. Capstone signal investigation

  1. The signal-management lifecycle recap
  2. Disproportionality is not causation; no signal is not no risk
  3. Learning path and next courses
  4. Course completion

  1. 📘 Bonus: Oracle Empirica Signal eBook (Free with purchase)

Course Benefits

Benefits ebook icon
Free eBook

Get our exclusive eBook with every purchase - a complete companion guide to the course, yours to keep forever

Benefits cpd_points icon
CPD Points

Gain Continuing Professional Development (CPD) Points, accredited by The Faculty of Pharmaceutical Medicine of the Royal College of Physicians of the United Kingdom. These can be used to count towards the distance learning element of any scheme that comes under the umbrella of The Academy of Medical Royal Colleges or any other scheme for which there is mutual recognition.

Benefits certification icon
Certification

Receive a personal certificate to show your subject knowledge on course completion.

Benefits affordable icon
Affordable

You get excellent value through our cost-effective prices. We can also offer you group discounts on larger purchases.

Benefits flexible icon
Flexibility

The course saves you time through the convenience of online availability. This lets you complete the interactive course at your own comfort.

Benefits up_to_date icon
Keep Up to Date

You will stay up to date with changes to EU Good Pharmacovigilance Practices (Module IX and Addendum I), EMA/EudraVigilance signal-management principles, CIOMS signal-detection guidance, MedDRA versioning and the statistical methods (PRR, ROR, EBGM, Information Component) as our training courses are constantly monitored, reviewed and updated.

Benefits industry_experts icon
Learn from Industry Experts

The course content has been developed by pharmacovigilance signal-management and safety-science practitioners to ensure learners can detect, validate, assess and track safety signals to current regulatory and good-practice standards using an Empirica-style workflow.


Our Certified Customers

novartis
NHS
takeda
roche
dhl

Learner Rating & Reviews

4.7
Average Rating
536 global ratings
87.0%
5.0%
3.0%
3.0%
2.0%
RC

Working with Whitehall training for the last two years of partnership has been a very successful experience – I have fast access to all the GCP course...

SM

I have finalised the demo for the ICH-GCP E6 R3 refresher course. Overall, I liked the content and the interface. I also want to thank Whitehall Train...